Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Modular gene enhancers may be suitable target in treatment of blood cancer

Modular gene enhancers may be suitable target in treatment of blood cancer

New biomaterials-based system improves T-cell production

New biomaterials-based system improves T-cell production

FDA grants approval for first drug to treat inherited breast cancer

FDA grants approval for first drug to treat inherited breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Researchers create ‘protocells’ for delivering drugs to deepest tumor regions

Researchers create ‘protocells’ for delivering drugs to deepest tumor regions

New report shows little improvement in survival among young adults with cancer

New report shows little improvement in survival among young adults with cancer

Leukemia patients currently ineligible for targeted therapy may benefit from new drugs

Leukemia patients currently ineligible for targeted therapy may benefit from new drugs

EMQ attends Arab Health for the second year to showcase healthcare revolution in Birmingham

EMQ attends Arab Health for the second year to showcase healthcare revolution in Birmingham

Newly identified germline variations increase risk of relapse or second cancers in leukemia patients

Newly identified germline variations increase risk of relapse or second cancers in leukemia patients

Study reveals a loophole in treatment of chronic lymphocytic leukemia

Study reveals a loophole in treatment of chronic lymphocytic leukemia

Study highlights pernicious effect of obesity on blood-making stem cells

Study highlights pernicious effect of obesity on blood-making stem cells

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Multifunctional protein also plays role in development of blood cells

Multifunctional protein also plays role in development of blood cells

Clinical benefit of new cancer therapies may justify the expensive price

Clinical benefit of new cancer therapies may justify the expensive price

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

Researchers reveal previously unknown mechanism that inhibits cells' ability to develop into tumors

Researchers reveal previously unknown mechanism that inhibits cells' ability to develop into tumors

Transfusion dependence reduces access to high-quality end-of-life care for leukemia patients

Transfusion dependence reduces access to high-quality end-of-life care for leukemia patients

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Study: Combination targeted therapy has high response rates in AML patients

Study: Combination targeted therapy has high response rates in AML patients